Krantz S B, Dessypris E N
J Clin Immunol. 1982 Jul;2(3):222-9. doi: 10.1007/BF00915225.
Antibody-dependent cellular cytotoxicity (ADCC) is a very sensitive mechanism for immune injury of target cells, which utilizes extremely low concentrations of antibody. We have developed a method for demonstrating this type of cytotoxicity to normal human erythroblasts. The latter were enriched 3- to 4-fold and were then labeled with 59Fe. Blood lymphocytes from the same donor were enriched to 93% and were added as effector cells at a 60:1 ratio to the target cells. After 4 hr at 37 degrees C, as 5- to 10-fold increase in the release of 59Fe occurred when the plasma or IgG from patients with pure red-cell aplasia was present. This activity was not present when the effector cells were absent. However, this activity was found in the remission plasmas of patients and was not found when autologous erythroblasts were used. These studies demonstrate a method for detecting ADCC to allogeneic normal human erythroblasts. This ADCC does not appear to be related to the disease since a similar autoimmune activity to the patients' own erythroid cells was not detected. Further studies are suggested using other effector cells in this system.
抗体依赖的细胞毒性作用(ADCC)是一种针对靶细胞的非常敏感的免疫损伤机制,它利用极低浓度的抗体。我们已经开发出一种方法来证明这种对正常人成红细胞的细胞毒性作用。将正常人成红细胞富集3至4倍,然后用59Fe进行标记。来自同一供体的血液淋巴细胞富集至93%,并以60:1的比例作为效应细胞添加到靶细胞中。在37℃孵育4小时后,当存在纯红细胞再生障碍性贫血患者的血浆或IgG时,59Fe的释放增加了5至10倍。当没有效应细胞时则不存在这种活性。然而,在患者的缓解期血浆中发现了这种活性,而当使用自体成红细胞时则未发现。这些研究证明了一种检测对同种异体正常人成红细胞的ADCC的方法。这种ADCC似乎与疾病无关,因为未检测到对患者自身红细胞系细胞的类似自身免疫活性。建议在该系统中使用其他效应细胞进行进一步研究。